ENZ-302

N/A

Report date: 2024/12/02 13:50:01
NME

Base Information

Drug NameENZ-302
Drug Alias NameENZ-302
ClassificationNatural product/Extract
Mechanisms of ActionTyrosine-protein kinase SRC inhibitors
TargetsTyrosine-protein kinase SRC
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEnzene Biosciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEnzene Biosciences Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A